BRUYAUX PHARMA
0542.935.031 · rovalta.com · 25/09/2026
BRUYAUX PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBRUYAUX PHARMA is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Mons. It employs on average 1,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0542.935.031
- Incorporation
- 12/12/2013
- Legal form
- Private limited company
- Registered office
- Rue de Montreuil sous Bois(H.) 78
7022 Mons · WallonieSee on map - Contributed capital
- 50 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,8 ETP
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 244,8 k € | +0.1% | 244,6 k € | +23.7% | 197,7 k € | -9.3% | 218,1 k € | +4.9% | 207,9 k € |
| EBITDA | 146,7 k € | -11.1% | 165,1 k € | +33.5% | 123,7 k € | -16.1% | 147,4 k € | +3.3% | 142,8 k € |
| Operating result | 114,6 k € | -14.1% | 133,4 k € | +81.6% | 73,5 k € | -36.3% | 115,4 k € | +4.7% | 110,2 k € |
| Net result | 73,7 k € | -18.2% | 90 k € | +106% | 43,7 k € | -42.3% | 75,8 k € | +15.7% | 65,6 k € |
| Balance sheet | |||||||||
| Equity | 465,2 k € | -8.1% | 506,1 k € | +21.6% | 416,1 k € | +11.7% | 372,4 k € | +25.6% | 296,6 k € |
| Total assets | 856,9 k € | +6.9% | 802 k € | +5.5% | 760 k € | +5.7% | 718,7 k € | +16.4% | 617,2 k € |
| Cash | 260 k € | +29.4% | 200,9 k € | +55.2% | 129,5 k € | -28.5% | 181 k € | +18.0% | 153,4 k € |
| Debts | 379,5 k € | +31.1% | 289,5 k € | -14.8% | 339,8 k € | +0.0% | 339,8 k € | +9.1% | 311,4 k € |
| Other | |||||||||
| Workforce | 1,8 ETP | +12.5% | 1,6 ETP | +6.7% | 1,5 ETP | 0.0% | 1,5 ETP | -6.3% | 1,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/08/2026 | 26/08/2025 | 30/08/2024 | 30/08/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 29/06/2026 | 30/06/2025 | 24/06/2024 | 26/06/2023 | 27/06/2022 | 28/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 26/08/2026 | French | |
| Abridged model | 31/12/2024 | 30/06/2025 | 26/08/2025 | French | |
| Abridged model | 31/12/2023 | 24/06/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 26/06/2023 | 30/08/2023 | French | |
| Abridged model | 31/12/2021 | 27/06/2022 | 31/08/2022 | French | |
| Abridged model | 31/12/2020 | 28/06/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 29/06/2020 | 30/09/2020 | French | |
| Abridged model | 31/12/2018 | 24/06/2019 | 29/08/2019 | French | |
| Abridged model | 31/12/2017 | 25/06/2018 | 28/08/2018 | French | |
| Abridged model | 31/12/2016 | 26/06/2017 | 29/08/2017 | French | |
| Abridged model | 31/12/2015 | 27/06/2016 | 29/08/2016 | French | |
| Abridged model | 31/12/2014 | 29/06/2015 | 27/08/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202573,7 k €↓
- 2024Annual accounts 202490 k €↑
- 2023Annual accounts 202343,7 k €↓
- 2022Annual accounts 202275,8 k €↑
- 2021Annual accounts 202165,6 k €↑
- 2020Annual accounts 202061,4 k €↑
- 2019Annual accounts 201956,3 k €↑
- 2018Annual accounts 201838,2 k €↑
- 2017Annual accounts 201720,2 k €↓
- 2016Annual accounts 201627,4 k €↓
- 2015Annual accounts 201541,7 k €↑
- 2014Annual accounts 201440,5 k €
- 12/12/2013IncorporationPrivate limited company